Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

SCM to Support BTG NDA

Published: Friday, April 26, 2013
Last Updated: Friday, April 26, 2013
Bookmark and Share
Will provide scale up for Varisolve launch.

SCM Pharma will assist BTG in preparation for the commercial launch of Varisolve® (polidocanol endovenous microfoam (PEM)), after providing clinical development consultancy for the product for several years.

The UK-based contract development and manufacturing organization (CDMO) has worked with specialist healthcare company BTG since 2005, assisting with clinical studies through to the recent pivotal Phase III clinical trial supply.

PEM is being developed by BTG as a comprehensive treatment for the appearance and symptoms of varicose veins. In the US alone over 40 million patients suffer from varicose veins.

To date, SCM Pharma has supported BTG with process development, sterile manufacturing, packaging and distribution to trial sites in the US.

The CDMO will now be named on the New Drug Application (NDA) for PEM as a commercial supplier and is prepared to further support BTG throughout the NDA review process.

Dianne Sharp, managing director at SCM Pharma, said: “We are very proud to be supporting BTG with its NDA for Varisolve®, as it is a product that we have helped them develop for many years.

“The complexities involved in developing, processing and producing this product illustrates the type of work we do here at SCM Pharma. Working with novel products, difficult processes and applications and often dangerous substances and APIs at relatively smaller scale is very much our sweet spot.”

SCM Pharma is an award-wining manufacturer specializing in the sterile production of products for clinical trials along with the supply of licensed drugs in niche commercial markets.

It is currently gearing up for the opening of its new commercial contract manufacturing facility that will reinforce its expertise in vial, ampoule and syringe filling, particularly when dealing with highly potent and toxic products that require aseptic filling.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

MHRA Approval for CDMO’s Commercial Facility
To supply licensed commercial products and aid clinical projects.
Thursday, June 20, 2013
MHRA Approves New SCM Pharma Commercial Facility
SCM Pharma’s new £6m ($10m) pharmaceutical contract manufacturing facility has been given the go ahead.
Thursday, June 20, 2013
Vial Filling Boost at SCM
UK-based CDMO invests over £500k in new vial filling equipment.
Thursday, March 15, 2012
SCM to Deliver Vial Filling Project
BrePco selects CDMO to initially produce clinical batches for eight clinical trial sites.
Friday, February 10, 2012
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Researchers Develop Software That Could Facilitate Drug Development
AptaTRACE can identify aptamers, potentially speed drug advancement.
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
New Medication Shows Promise Against Liver Fibrosis in Animal Studies
Liver fibrosis is a gradual scarring of the liver that puts people at risk for progressive liver disease and liver failure.
Raw Eggs Deemed Safe to Eat
A report published today by the Advisory Committee on the Microbiological Safety of Food (ACMSF) into egg safety has shown a major reduction in the risk from salmonella in UK eggs.
Monitoring TTX Toxin in Shellfish
In a number of small studies, mussels and oysters from the eastern and northern part of the Oosterschelde in Holland were found to contain tetrodotoxin (TTX).
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!